Clinical trial
Role of CYP2B6 Polymorphisms in Ketamine Metabolism and Clearance
NCT01988922 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of CYP2B6 Polymorphisms in Ketamine Metabolism and Clearance
- Lead sponsor
- Washington University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- May 31, 2017
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers